Pharma Journalist - Page 6 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Aditxt Plans Public Spinout of Ignite Proteomics

FDA Approves Extended Dosing Schedule for EBGLYSS

FDA Expands HYMPAVZI Approval for More Hemophilia Patients

Johnson & Johnson Buys Firefly Bio for $1 Billion

Incyte to Acquire Vega Therapeutics in $1.25 Billion Deal

Owkin, Sanofi Expand AI Drug Development Partnership

Wegovy Pill Tops Three Million U.S. Prescriptions

Alnylam, Inceptive Forge $2 Billion AI Drug Discovery Deal

Lonza, Stipple Bio Partner on Precision Cancer ADCs

FDA Grants Breakthrough Status to Biogen’s Salanersen